Computing towards a cure

With the help of IBM, the Huntington’s disease not-for-profit CHDI and its partners have been bringing artificial intelligence to HD research and developing models of disease progression that integrate data from the level of genes to clinical outcomes.

The partnership aims to drive drug discovery by marrying CHDI Foundation Inc.’s network and access to patient data with IBM Corp.’s expertise in AI to generate models that will generate a steady stream of new projects for drug developers to pick up. ...